Live feed
Filing
SC 13G
SC 13G0001408408-17-000027·Scinai Immunotherapeutics Ltd.
Schedule 13G ownership disclosure
BIONDVAX PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 09073Q105
Event date: 2017-09-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 19,000,000
- Percent of class
- 7.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001408408-17-000027
- Form type
- SC 13G
- Filer
- Scinai Immunotherapeutics Ltd.
- CIK
- CIK 1611747
- Filed
- Sep 26, 2017
- Reporting period
- Sep 18, 2017
- Description
- Schedule 13G beneficial ownership